Diabetes Mellitus, Non-Insulin-Dependent
Item
has a clinical diagnosis of type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
has an hba1c >7.0% and ≤10.0%
boolean
C0019018 (UMLS CUI [1])
Body mass index
Item
has a bmi of ≥25 kg/m^2 and ≤50 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Insulin regime | Insulin U/day | Insulin regime Pre-existing Absent | Patient Appropriate Initiation Basal insulin
Item
has been on a regimen of insulin for less than 6 months and is taking less than 50 u total of insulin per day, or has not been on a pre existing insulin regimen and is a candidate for the initiation of basal insulin therapy
boolean
C0557978 (UMLS CUI [1])
C0021641 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0557978 (UMLS CUI [3,1])
C2347662 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0030705 (UMLS CUI [4,1])
C1548787 (UMLS CUI [4,2])
C1704686 (UMLS CUI [4,3])
C0650607 (UMLS CUI [4,4])
Recurrent severe hypoglycemia Treatment required for
Item
has experienced recurrent severe hypoglycemia requiring assistance during the past 6 months
boolean
C0342316 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Requirement Pharmaceutical Preparations Stimulating Gastrointestinal Motility
Item
requires the use of drugs that stimulate gastrointestinal motility
boolean
C1514873 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C1948023 (UMLS CUI [1,3])
C0017184 (UMLS CUI [1,4])
Symlin | Study Subject Participation Status
Item
has been previously treated with symlin (or has participated in a symlin clinical study)
boolean
C1174780 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
Anti-Obesity Agents Non-Prescription | Herbal supplement | Anti-Obesity Agents | orlistat | Xenical | sibutramine | Meridia | Systemic steroids Oral | Systemic steroids Intravenous | Systemic steroids Intramuscular | Steroids Oral | inhaled steroids | Steroids Intrapulmonary | Systemic Absorption Rate High | Pharmaceutical Preparations Affecting Gastrointestinal Motility | Dopamine Antagonists | Metoclopramide | Reglan | Opiates | Anticholinergic Agents | Macrolide Antibiotics chronic | Erythromycin | Erythromycin Derivative | Investigational New Drugs
Item
is currently being treated with any of the following medications: *over-the-counter antiobesity agents (including, but not limited to, herbal supplements) or prescription antiobesity agents (including orlistat [xenical®] and sibutramine [meridia®]); *oral, intravenous, or intramuscular systemic steroids by oral or potent inhaled or intrapulmonary steroids that are known to have a high rate of systemic absorption; *drugs that directly affect gastrointestinal motility, including but not limited to: dopamine antagonists (e.g., metoclopramide [reglan®]), opiates or anticholinergics; and chronic (more than 10 days within a 6-month period) macrolide antibiotics such as erythromycin and newer derivatives; *investigational medications
boolean
C0376607 (UMLS CUI [1,1])
C0013231 (UMLS CUI [1,2])
C1504473 (UMLS CUI [2])
C0376607 (UMLS CUI [3])
C0076275 (UMLS CUI [4])
C0732649 (UMLS CUI [5])
C0074493 (UMLS CUI [6])
C0635898 (UMLS CUI [7])
C2825233 (UMLS CUI [8,1])
C1527415 (UMLS CUI [8,2])
C2825233 (UMLS CUI [9,1])
C1522726 (UMLS CUI [9,2])
C2825233 (UMLS CUI [10,1])
C1556154 (UMLS CUI [10,2])
C0038317 (UMLS CUI [11,1])
C1527415 (UMLS CUI [11,2])
C2065041 (UMLS CUI [12])
C0038317 (UMLS CUI [13,1])
C1522224 (UMLS CUI [13,2])
C3850076 (UMLS CUI [14,1])
C1521828 (UMLS CUI [14,2])
C0205250 (UMLS CUI [14,3])
C0013227 (UMLS CUI [15,1])
C0392760 (UMLS CUI [15,2])
C0017184 (UMLS CUI [15,3])
C0242702 (UMLS CUI [16])
C0025853 (UMLS CUI [17])
C0034977 (UMLS CUI [18])
C0376196 (UMLS CUI [19])
C0242896 (UMLS CUI [20])
C0003240 (UMLS CUI [21,1])
C0205191 (UMLS CUI [21,2])
C0014806 (UMLS CUI [22])
C0014806 (UMLS CUI [23,1])
C1527240 (UMLS CUI [23,2])
C0013230 (UMLS CUI [24])
Eating Disorders | Anorexia | Bulimia | Bariatric Surgery | Gastric Bypass | Partitioning of stomach using band | Gastroplasty
Item
has a history or presence of any of the following: *eating disorders (including anorexia and/or bulimia); *bariatric surgery (gastric bypass, gastric banding, or gastroplasty)
boolean
C0013473 (UMLS CUI [1])
C0003123 (UMLS CUI [2])
C0006370 (UMLS CUI [3])
C1456587 (UMLS CUI [4])
C0017125 (UMLS CUI [5])
C1960832 (UMLS CUI [6])
C0017193 (UMLS CUI [7])
Enrollment Weight Reduction Program | Enrollment Weight Reduction Program Planned
Item
is currently enrolled in a weight-loss program or plans to enroll in a weight-loss program before termination of the study
boolean
C1516879 (UMLS CUI [1,1])
C3179079 (UMLS CUI [1,2])
C1516879 (UMLS CUI [2,1])
C3179079 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
Blood Donation | Blood Donation Planned
Item
has donated blood within 30 days of study start or plans to donate blood during the duration of the study
boolean
C0005794 (UMLS CUI [1])
C0005794 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])